N
5.33
0.10 (1.91%)
| 前收盘价格 | 5.23 |
| 收盘价格 | 5.24 |
| 成交量 | 4,019,215 |
| 平均成交量 (3个月) | 7,404,311 |
| 市值 | 1,156,812,544 |
| 预期市盈率 (P/E Forward) | 16.00 |
| 价格/销量 (P/S) | 1.32 |
| 股市价格/股市净资产 (P/B) | 0.570 |
| 52周波幅 | |
| 利润日期 | 28 Jul 2025 - 1 Aug 2025 |
| 营业毛利率 | -53.56% |
| 营业利益率 (TTM) | 2.45% |
| 稀释每股收益 (EPS TTM) | -2.23 |
| 季度收入增长率 (YOY) | -3.40% |
| 总债务/股东权益 (D/E MRQ) | 33.61% |
| 流动比率 (MRQ) | 3.91 |
| 营业现金流 (OCF TTM) | 68.45 M |
| 杠杆自由现金流 (LFCF TTM) | 1.26 M |
| 资产报酬率 (ROA TTM) | 0.59% |
| 股东权益报酬率 (ROE TTM) | -16.71% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | Neogen Corporation | 看跌 | 看跌 |
AIStockmoo 评分
-1.1
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | -1.13 |
|
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 0.38% |
| 机构持股比例 | 128.88% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Gates Capital Management, Inc. | 31 Mar 2025 | 9,156,922 |
| 52周波幅 | ||
| 中 | 10.00 (87.62%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 30 Jun 2025 | 10.00 (87.62%) | 购买 | 4.78 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合